• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

法国中枢神经系统肿瘤的描述性流行病学:来自 2000-2007 年吉伦特登记处的数据。

Descriptive epidemiology of CNS tumors in France: results from the Gironde Registry for the period 2000-2007.

机构信息

Laboratoire Santé Travail Environnement, Centre INSERM U 897, Université Victor Segalen Bordeaux 2, 146 rue Léo Saignat, 33076 Bordeaux, France.

出版信息

Neuro Oncol. 2011 Dec;13(12):1370-8. doi: 10.1093/neuonc/nor120. Epub 2011 Oct 6.

DOI:10.1093/neuonc/nor120
PMID:21980160
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3223087/
Abstract

An increase in the incidence of CNS tumors has been observed in many countries in the last decades. The reality of this trend has been much debated, as it has happened during a period when computer-assisted tomography and MRI have dramatically improved the detection of these tumors. The Gironde CNS Tumor Registry provides here the first data on CNS tumor incidence and trends in France for all histological types, including benign and malignant tumors, for the period 2000-2007. Incidence rates were calculated globally and for each histological subtype. For trends, a piecewise log-linear model was used. The overall annual incidence rate was found to be 17.6/100 000. Of this rate, 7.9/100 000 were neuroepithelial tumors and 6.0/100 000 were meningiomas. An overall increase in CNS tumor incidence was observed from 2000 to 2007, with an annual percent change (APC) of +2.33%, which was explained mainly by an increase in the incidence of meningiomas over the 8-year period (APC = +5.4%), and also more recently by an increase in neuroepithelial tumors (APC = +7.45% from 2003). The overall increase was more pronounced in women and in the elderly, with an APC peaking at +24.65% in subjects 85 and over. The increase in the incidence rates we observed may have several explanations: not only improvements in registration, diagnosis, and clinical practice, but also changes in potential risk factors.

摘要

在过去几十年中,许多国家都观察到中枢神经系统肿瘤的发病率有所增加。这种趋势的真实性存在很大争议,因为它发生在计算机辅助断层扫描和磁共振成像显著提高了这些肿瘤检测能力的时期。吉伦特中枢神经系统肿瘤登记处提供了法国所有组织学类型(包括良性和恶性肿瘤)的中枢神经系统肿瘤发病率和趋势的首批数据,时间范围为 2000 年至 2007 年。发病率是根据全球和每种组织学亚型计算的。对于趋势,使用分段对数线性模型。总体年发病率为 17.6/100000。在这个比率中,7.9/100000 是神经上皮肿瘤,6.0/100000 是脑膜瘤。从 2000 年到 2007 年,中枢神经系统肿瘤的发病率总体呈上升趋势,年变化百分比(APC)为+2.33%,这主要归因于 8 年间脑膜瘤发病率的上升(APC = +5.4%),最近神经上皮肿瘤的发病率也有所上升(APC = +7.45%,从 2003 年开始)。在女性和老年人中,总体上升更为明显,85 岁及以上人群的 APC 峰值为+24.65%。我们观察到的发病率上升可能有几个解释:不仅是登记、诊断和临床实践的改进,还有潜在危险因素的变化。

相似文献

1
Descriptive epidemiology of CNS tumors in France: results from the Gironde Registry for the period 2000-2007.法国中枢神经系统肿瘤的描述性流行病学:来自 2000-2007 年吉伦特登记处的数据。
Neuro Oncol. 2011 Dec;13(12):1370-8. doi: 10.1093/neuonc/nor120. Epub 2011 Oct 6.
2
Increasing incidence of central nervous system (CNS) tumors (2000-2012): findings from a population based registry in Gironde (France).中枢神经系统(CNS)肿瘤发病率上升(2000-2012):法国吉伦特地区基于人群的注册研究结果。
BMC Cancer. 2018 Jun 14;18(1):653. doi: 10.1186/s12885-018-4545-9.
3
Descriptive epidemiology of primary malignant and non-malignant central nervous tumors in Spain: Results from the Girona Cancer Registry (1994-2013).西班牙原发性恶性和非恶性中枢神经肿瘤的描述性流行病学:赫罗纳癌症登记处的结果(1994 - 2013年)
Cancer Epidemiol. 2017 Oct;50(Pt A):1-8. doi: 10.1016/j.canep.2017.07.005. Epub 2017 Jul 21.
4
Italian cancer figures, report 2012: Cancer in children and adolescents.《2012年意大利癌症数据报告:儿童和青少年癌症》
Epidemiol Prev. 2013 Jan-Feb;37(1 Suppl 1):1-225.
5
Descriptive Epidemiology of Ependymal Tumors in Gironde, France: Results from the Gironde Registry for the 2000-2018 Period.法国吉伦特省室管膜瘤的描述性流行病学:吉伦特登记处2000 - 2018年期间的结果
Neuroepidemiology. 2022;56(4):250-260. doi: 10.1159/000523954. Epub 2022 Mar 23.
6
Geographical variation in malignant and benign/borderline brain and CNS tumor incidence: a comparison between a high-income and a middle-income country.脑和中枢神经系统肿瘤良恶性/交界性的发病率的地域差异:高收入和中等收入国家之间的比较。
J Neurooncol. 2020 Sep;149(2):273-282. doi: 10.1007/s11060-020-03595-5. Epub 2020 Aug 19.
7
[Incidence and mortality of central nervous system tumors in France: trends over the period 1978-2000 and influence of registration practices on results].[法国中枢神经系统肿瘤的发病率和死亡率:1978 - 2000年期间的趋势以及登记做法对结果的影响]
Rev Epidemiol Sante Publique. 2006 Oct;54(5):399-406. doi: 10.1016/s0398-7620(06)76738-4.
8
Registration, incidence patterns, and survival trends of central nervous system tumors among children in Germany 1980-2019: An analysis of 40 years based on data from the German Childhood Cancer Registry.德国 1980-2019 年儿童中枢神经系统肿瘤的登记、发病模式和生存趋势:基于德国儿童癌症登记处数据的 40 年分析。
Pediatr Blood Cancer. 2024 Jun;71(6):e30954. doi: 10.1002/pbc.30954. Epub 2024 Mar 26.
9
A Cohort Study of CNS Tumors in Multiple Endocrine Neoplasia Type 1.1型多发性内分泌腺瘤病中枢神经系统肿瘤的队列研究
Clin Cancer Res. 2024 Jul 1;30(13):2835-2845. doi: 10.1158/1078-0432.CCR-23-3308.
10
Descriptive epidemiology of germ cell tumors of the central nervous system diagnosed in the United States from 2006 to 2015.描述性流行病学:美国 2006 年至 2015 年期间诊断的中枢神经系统生殖细胞肿瘤。
J Neurooncol. 2019 Jun;143(2):251-260. doi: 10.1007/s11060-019-03173-4. Epub 2019 Apr 25.

引用本文的文献

1
Recommendations on the management of meningioma and sex hormone therapy: The results of a collaborative effort between neurosurgical, endocrine and gynecological societies.脑膜瘤管理与性激素治疗的建议:神经外科、内分泌科和妇科协会合作的成果
Brain Spine. 2024 Dec 9;5:104154. doi: 10.1016/j.bas.2024.104154. eCollection 2025.
2
Survival analysis and associated factors of highgrade glioma patients.高级别胶质瘤患者的生存分析及相关因素
Biomedica. 2024 May 30;44(2):191-206. doi: 10.7705/biomedica.6742.
3
Descriptive epidemiology of 30,223 histopathologically confirmed meningiomas in France: 2006-2015.法国 2006-2015 年 30223 例组织病理学证实的脑膜瘤的描述性流行病学研究。
Acta Neurochir (Wien). 2024 May 14;166(1):214. doi: 10.1007/s00701-024-06093-z.
4
Prevalence and trend of atrial fibrillation and its associated risk factors among the population from nationwide health check-up centers in China, 2012-2017.2012 - 2017年中国全国健康体检中心人群中心房颤动的患病率、趋势及其相关危险因素
Front Cardiovasc Med. 2023 May 31;10:1151575. doi: 10.3389/fcvm.2023.1151575. eCollection 2023.
5
Temporal trends in the incidence of malignant and nonmalignant primary brain and central nervous system tumors by the method of diagnosis in England, 1993-2017.1993-2017 年英国采用诊断方法的脑和中枢神经系统原发性良、恶性肿瘤发病率的时间趋势。
Neuro Oncol. 2023 Jun 2;25(6):1177-1192. doi: 10.1093/neuonc/noad001.
6
High prevalence of adrenal cortical adenomas in patients with cerebral meningiomas.脑脑膜瘤患者中肾上腺皮质腺瘤的高发率。
J Endocrinol Invest. 2023 Apr;46(4):763-768. doi: 10.1007/s40618-022-01935-y. Epub 2022 Oct 21.
7
GPER Agonist G-1 Disrupts Tubulin Dynamics and Potentiates Temozolomide to Impair Glioblastoma Cell Proliferation.GPER 激动剂 G-1 破坏微管动力学并增强替莫唑胺抑制胶质母细胞瘤细胞增殖的作用。
Cells. 2021 Dec 7;10(12):3438. doi: 10.3390/cells10123438.
8
Incidence of Benign Meningiomas in the United States: Current and Future Trends.良性脑膜瘤在美国的发病率:当前和未来趋势。
JNCI Cancer Spectr. 2021 Apr 8;5(3). doi: 10.1093/jncics/pkab035. eCollection 2021 Jun.
9
Primary central nervous system tumors in Sergipe, Brazil: descriptive epidemiology between 2010 and 2018.巴西塞尔希培州的原发性中枢神经系统肿瘤:2010年至2018年的描述性流行病学
Arq Neuropsiquiatr. 2021 Jun;79(6):504-510. doi: 10.1590/0004-282X-ANP-2020-0151. Epub 2021 Jul 5.
10
The incidence of major subtypes of primary brain tumors in adults in England 1995-2017.1995 年至 2017 年英格兰成年人原发性脑肿瘤主要亚型的发病率。
Neuro Oncol. 2021 Aug 2;23(8):1371-1382. doi: 10.1093/neuonc/noab076.

本文引用的文献

1
Are reported increases in incidence of primary CNS tumours real? An analysis of longitudinal trends in England, 1979-2003.原发性中枢神经系统肿瘤的发病率真的增高了吗?对英格兰 1979-2003 年纵向趋势的分析。
Eur J Cancer. 2010 Jun;46(9):1607-16. doi: 10.1016/j.ejca.2010.02.007. Epub 2010 Mar 1.
2
Time trends in brain tumor incidence rates in Denmark, Finland, Norway, and Sweden, 1974-2003.1974 - 2003年丹麦、芬兰、挪威和瑞典脑肿瘤发病率的时间趋势
J Natl Cancer Inst. 2009 Dec 16;101(24):1721-4. doi: 10.1093/jnci/djp415.
3
The Austrian Brain Tumour Registry: a cooperative way to establish a population-based brain tumour registry.奥地利脑肿瘤登记处:建立基于人群的脑肿瘤登记处的合作方式。
J Neurooncol. 2009 Dec;95(3):401-411. doi: 10.1007/s11060-009-9938-9. Epub 2009 Jun 28.
4
Incidence of first primary central nervous system tumors in California, 2001-2005.2001 - 2005年加利福尼亚州原发性中枢神经系统肿瘤的发病率
J Neurooncol. 2009 Sep;94(2):249-61. doi: 10.1007/s11060-009-9864-x. Epub 2009 Apr 2.
5
The controversy about a possible relationship between mobile phone use and cancer.关于使用手机与癌症之间可能存在的关系的争议。
Environ Health Perspect. 2009 Mar;117(3):316-24. doi: 10.1289/ehp.11902. Epub 2008 Sep 26.
6
Age-incidence patterns of primary CNS tumors in children, adolescents, and adults in England.英格兰儿童、青少年和成人原发性中枢神经系统肿瘤的年龄发病率模式。
Neuro Oncol. 2009 Aug;11(4):403-13. doi: 10.1215/15228517-2008-097. Epub 2008 Nov 24.
7
The incidence trends of primary brain tumors in Saskatchewan from 1970 to 2001.1970年至2001年萨斯喀彻温省原发性脑肿瘤的发病趋势。
Can J Neurol Sci. 2007 May;34(2):181-6. doi: 10.1017/s0317167100006016.
8
[Incidence and mortality of central nervous system tumors in France: trends over the period 1978-2000 and influence of registration practices on results].[法国中枢神经系统肿瘤的发病率和死亡率:1978 - 2000年期间的趋势以及登记做法对结果的影响]
Rev Epidemiol Sante Publique. 2006 Oct;54(5):399-406. doi: 10.1016/s0398-7620(06)76738-4.
9
Temporal trends in incidence of primary brain tumors in the United States, 1985-1999.1985 - 1999年美国原发性脑肿瘤发病率的时间趋势
Neuro Oncol. 2006 Jan;8(1):27-37. doi: 10.1215/S1522851705000323.
10
Incidence of intracranial meningiomas in Denmark, Finland, Norway and Sweden, 1968-1997.1968 - 1997年丹麦、芬兰、挪威和瑞典颅内脑膜瘤的发病率
Int J Cancer. 2005 Dec 20;117(6):996-1001. doi: 10.1002/ijc.21255.